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Catalytic mechanism of the colistin resistance
protein MCR-1†
Reynier Suardíaz, *a,b,c Emily Lythell, a,d Philip Hinchliffe, d
Marc van der Kamp, a,b James Spencer, d Natalie Fey a and
Adrian J. Mulholland *a
The mcr-1 gene encodes a membrane-bound Zn2+-metalloenzyme,
MCR-1, which catalyses phosphoethanolamine transfer onto bac-
terial lipid A, making bacteria resistant to colistin, a last-resort anti-
biotic. Mechanistic understanding of this process remains incom-
plete. Here, we investigate possible catalytic pathways using DFT
and ab initio calculations on cluster models and identify a complete
two-step reaction mechanism. The first step, formation of a
covalent phosphointermediate via transfer of phosphoethanolamine
from a membrane phospholipid donor to the acceptor Thr285, is
rate-limiting and proceeds with a single Zn2+ ion. The second step,
transfer of the phosphoethanolamine group to lipid A, requires an
additional Zn2+. The calculations suggest the involvement of the
Zn2+ orbitals directly in the reaction is limited, with the second Zn2+
acting to bind incoming lipid A and direct phosphoethanolamine
addition. The new level of mechanistic detail obtained here, which
distinguishes these enzymes from other phosphotransferases, will
aid in the development of inhibitors specific to MCR-1 and related
bacterial phosphoethanolamine transferases.
Introduction
Antimicrobial resistance (AMR) is a major and growing
problem in many areas of medicine. AMR has been recognised
as one of the greatest threats to human health by the World
Economic Forum (WEF).1 The polymyxin colistin is currently a
‘last-resort’ antibiotic for extensively-resistant Gram-negative
bacteria. Colistin is a positively charged cyclic lipopeptide that
is thought to bind to the outer bacterial membrane.2
Resistance arises through chemical modification of lipid A,
catalysed by enzymes including MCR-1 (mobilized colistin re-
sistance-1) and relatives (such as Neisseria EptA),3 that reduces
binding of the antibiotic. The mcr-1 gene was identified
recently4 and is the major cause of colistin failure for
Escherichia coli, a leading cause of bloodstream infections.
Although the structure of the MCR-1 catalytic domain was
reported by some of us,5 very little experimental information is
available regarding the modes of substrate binding and reac-
tion mechanism of this enzyme. It is clear that MCR-1 is an
integral, Zn2+-dependent inner-membrane protein, with a
large periplasmic domain containing the catalytic centre, but
the zinc stoichiometry of the system remains uncertain.5
Establishing these crucial features should help in the develop-
ment of inhibitors to counteract colistin resistance.
Early attempts to simulate phosphoethanolamine (PEA)
transfer to the Thr285 acceptor (the first step of the reaction,
see Fig. 1) using minimalistic models did not find reasonable
reaction barriers and could not explain the role of His395, a
residue whose mutation affects colistin susceptibility of
MCR-1-expressing bacteria.5 In a more recent report, we pre-
sented the results of molecular dynamics simulations and pre-
liminary density functional theory (DFT) calculations designed
to investigate the feasibility of PEA transfer by the mono- and
di-zinc forms of the MCR-1 catalytic domain identified crystal-
lographically.6 Those calculations suggested that MCR-1 can
support PEA transfer to Thr285 with only one Zn2+ ion bound.6
Here, we have used a cluster model of the MCR-1 active site to
model, for the first time, both steps of the catalytic mecha-
nism using DFT and ab initio calculations. Cluster models
have been used successfully to study enzyme mechanisms for
many years, especially for metallo-proteins.7–9 Cluster models
are not without limitations, such as non-inclusion of confor-
mational sampling and dynamics, leading to heavy reliance on
†Electronic supplementary information (ESI) available: Additional compu-
tational details for the DFT and ab initio calculations, details about the orien-
tation of the substrate, tables with all data for calculated energies and correc-
tions, calculations of sensitivity of the second step to ε and calculations about
the role of the Zn2+ ion in the rate-determining step. Cartesian coordinates of all
the stationary points presented in this report. See DOI: 10.1039/d0ob02566f
aCentre for Computational Chemistry, School of Chemistry, University of Bristol,
Cantock’s Close, Bristol BS8 1TS, UK. E-mail: reysuard@ucm.es,
adrian.mulholland@bristol.ac.uk
bSchool of Biochemistry, University of Bristol, University Walk, Bristol BS8 1TD, UK
cDepartamento de Química Física, Facultad de Química, Universidad Complutense,
28040 Madrid, Spain
dSchool of Cellular and Molecular Medicine, University of Bristol, University Walk,
Bristol BS8 1TD, UK



























































































starting structures, and the use of an implicit solvent model to
approximate the cluster’s environment that ignores any
specific influences. However, we consider that for our pur-
poses cluster models represent an appropriate combination of
accuracy and computational efficiency with which to investi-
gate alternative reaction pathways in this relatively complex
system. The applications and limitations of cluster models are
discussed in detail in many excellent reviews.7,10 In this work
we address questions about the number of Zn2+ ions needed for
catalysis, the specific role of these in the reaction, the protona-
tion states of the active site histidine residues 395 and 478 and
the structures and energetics of the most probable reaction
paths, including barrier heights and the identity of the rate-lim-
iting step. The resulting detailed knowledge of the key electro-
static and structural factors required for catalysis of PEA trans-
fer, as well as identification of reaction pathways, provides infor-
mation that may be exploited to generate candidate MCR inhibi-
tors. Combining approved drugs with inhibitors of resistance is
an established approach to overcoming AMR and prolonging
the clinically-useful lifetimes of antibiotics,11,12 an important
consideration given the continuing weakness of the antibiotic
discovery pipeline for Gram-negative bacteria in particular.13
Cluster model and calculations
Calculations were performed on cluster models derived from
X-ray structures determined in previous work, PDB code:
5LRN.5 Note that only one zinc site (Zn1 in Fig. 2 and 3), tetra-
hedrally coordinated by MCR-1 residues Glu246, His466,
Asp465 and Thr285, is conserved in most PEA transferases.5
This is the Zn2+ ion position (Zn2þ1 ) used hereafter when refer-
ring to a mono-zinc structure. Substrates for the first (phos-
phatidylethanolamine, PEA) and second (lipid A) steps of the
reaction were modelled by deprotonated dimethyl- and methyl-
Fig. 1 Model of the MCR-1 enzyme (cyan, cartoon) based upon MCR-1
catalytic domain crystal structure5 and the full-length N. meningitidis
EptA structure40 shown embedded in bacterial inner membrane
(coloured spheres). Mono-Zn active site with PEA-donor phospholipid
substrate in coloured sticks. Only polar protons are shown.
Fig. 2 First step of the reaction: phosphoethanolamine transfer to the protein. Stationary points of the proposed reaction pathway are shown in 3D
as sticks (top, only selected protons shown, transferring protons in white spheres) and in 2D (bottom). (A) Reactant state. (B) Transition state, con-
certed transfer of two protons and formation and cleavage of P–O bonds. (C) Product state before substrate departure. Zn-ligand coordination dis-
tances indicated in black.
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phosphate molecules respectively (see Fig. 2 and ESI†). In the
case of the two-Zn2+ ion system, the initial position of the
second Zn2+ ion (Zn2 in Fig. 3) was taken from the di-zinc
MCR-1 crystal structure (PDB code: 5LRM).5 All Cα atoms were
kept frozen at their corresponding positions in the X-ray
crystal structure during the calculations to preserve the
approximate spatial arrangement of the residues. The cluster
model for PEA transfer to the protein (step 1 of the reaction)
consisted of 95 atoms and the cluster model for PEA transfer
to lipid A (step 2 of the reaction) consisted of 99 atoms. The
total charge of the models takes the value 0, ±1 depending
upon the protonation states of the histidine residues.
Geometry optimizations were performed using the
B3LYP-GD3BJ method (standard B3LYP functional14 with the
D3 version of Grimme’s dispersion correction with Becke–
Johnson damping)15 as implemented in the Gaussian 09
package.16 Inclusion of dispersion is important in modelling
enzyme-catalysed reactions with DFT.17 A combination of the
6-31+G(d,p) basis set for the phosphorus and the oxygen
atoms coordinated to Zn2+, the SDD Stuttgart/Dresden effective
core potential for Zn, and the 6-31G(d) basis set for all other
atoms, was used. This combination of functional and basis set
has proved to deliver satisfactory results when modelling
enzyme reactions,18–20 but in order to test the accuracy of the
DFT results, additional ab initio single point calculations at
the RI-SCS-MP2 level and a larger basis set aug-cc-pVTZ were
performed in Orca v4.2.3.21,22 SCS-MP223 has been shown to
give more accurate results than pure MP2 for (enzyme) reaction
barriers and energies.24–27 Solvation effects were taken into
account by the use of the conductor-like polarized continuum
model (C-PCM)28 and a dielectric constant, ε = 4, as widely
used in DFT cluster model calculations of enzymes.7,8 It was
previously demonstrated that the first step of the reaction was
not sensitive to the exact ε value used.6 Here, we show that the
same applies for the second step of the reaction (Table S4†).
Since typically the effect of ε on DFT cluster model calculations
saturates with increasing system size,29 we consider the rela-
tively small cluster used here to be appropriate for this system.
Frequency calculations were performed at the same level of
theory as the geometry optimizations to obtain free energy cor-
rections (at 298.15 K and 1 atm pressure) and to confirm the
nature of the stationary points. Due to use of frozen atoms in
the model, some imaginary frequencies occur at the stationary
points, but they are small and confined to the vicinity of the
frozen atoms. Our discussion focuses on the ‘best method’
data calculated, but a full breakdown of energies can be found
in the ESI.†
Phosphoethanolamine transfer to the
protein
Possible mechanisms for PEA transfer to the Thr285 acceptor,
the first step of the two-step reaction mechanism, have pre-
viously been studied using DFT cluster model calculations.5,6
Here we explored an expanded range of alternative mecha-
nisms, assessed these using higher levels of theory, and
extended the study to the whole reaction. Exploratory studies
of the different potential reaction pathways and different
choices of protonation states for the histidine residues were
carried out using semiempirical PM6 Hamiltonian and B3LYP/
6-31G(d) levels of theory before being submitted to
B3LYP-GD3BJ calculations and the previously described combi-
nation of basis sets (see ESI for a detailed description and
Table S1† for results). The orientation of the incoming sub-
strates in the model was based on the likely orientation of
MCR-1 in the membrane (Fig. 1 and ESI, section S2†).
Pathways assessed included (but were not limited to): a.
shuttling of a proton to the leaving group by the transient
phosphoryl group; b. cleavage of the phosphate group con-
certed with proton transfers from Thr285 to Glu246 and
His395 to the leaving group; c. the same pathway with His478
protonated; and d. a two Zn2+ ion-mechanism with Thr285
deprotonated by Glu246 and the leaving group stabilised by
the second metal ion. Other attempts involving a non-proto-
nated leaving group were also considered and discarded. Most
pathways tested were discarded due to failure to find a tran-
sition state, although preliminary estimations pointed to
much higher barriers. All viable and complete pathways are
shown in Table S1.† We then confirmed, on the basis of com-
paring free energies and barrier heights, that the most likely
reaction path for PEA transfer from the bacterial lipid mem-
brane to the protein involves nucleophilic attack of Thr285 on
the phosphate centre of the phospholipid, concerted with acti-
vation of Thr285 by Glu246 and a proton transfer from His395
to the dephosphorylated lipidic leaving group (Fig. 2). This
phosphate cleavage concerted with proton transfer is evi-
denced by the changes in geometry from reactants to products
reflected in the normal mode of the transition state imaginary
frequency (see animation in ESI†). Concerted reaction paths
have been found to be lower in energy than the corresponding
stepwise paths observed in other phosphate-processing
enzymes.30–32 The same concerted reaction path is found if
both histidine residues 395 and 478 are protonated, with a
potential energy reaction barrier height of 12.6 kcal mol−1 at
the SCS-MP2 level (comparing favourably with the barrier of
19.1 kcal mol−1 obtained when only His395 is protonated) and
an energy of reaction of −8.8 kcal mol−1 (Table S1†). When
taking into account the free energy and solvent corrections
from DFT calculations, this gave a free energy reaction barrier
of 16.9 kcal mol−1 with a corresponding −8.0 kcal mol−1 free
energy of reaction (Fig. 2 and Table 1). As the pKa of the conju-
gate acid of imidazole is approximately 7,33 small shifts in pH
could easily change the protonation state of histidine side
chains. Proton affinity calculations were thus performed and
showed a preference for histidine residues 395 and 478 to be
protonated. This preference increases in the presence of the
phosphorylated substrate, see Table S2† for details. As pre-
viously reported,5 mutation of His395 to Ala completely
destroys the activity of the enzyme, suggesting a direct involve-
ment of this residue in the reaction mechanism, consistent
with our proposed reaction pathway.
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The same procedure was followed for the two-Zn2+ system.
A transition state structure was found, indicating a similar
pathway to that observed in the one-Zn2+ system. However, we
could not identify a reactant state connected to this transition
state compatible with the crystal structure: any effort to locate
it led to a geometry in which His466 changed from coordinat-
ing the primary metal ion (Zn2þ1 ) to coordinating the second
zinc (Zn2þ2 ). The values reported in Table 1 correspond to this
system, with a reactant state not matching the crystal structure.
On the other hand, the single point energy of a hypothetical
reactant state geometry where His466 stays coordinated to was
calculated. The resulting reaction barrier for PEA transfer to
Thr285 implies that the second Zn2+ ion is not required for the
first step of the reaction mechanism since it can proceed with
a single Zn2+ ion.
Phosphoethanolamine transfer to the
lipid A
The second step of the reaction is assumed to be the nucleo-
philic attack of one of the phosphate head groups attached to
lipid A on the phosphoryl group of PEA attached to Thr285. To
model this process, various reaction pathways equivalent to
those tested for the first step were assessed, and most dis-
carded as we were unable to find a TS structure for the system
with one Zn2+ ion. In contrast, it was easy to find all stationary
points for the system when two Zn2+ ions were present (Fig. 3).
For the reactant state, the first Zn2+ ion (Zn2þ1 ) is tightly co-
ordinated to one oxygen atom of the phosphoryl group
attached to Thr285 (distance of 2.0 Å) and the side chain
oxygen of Thr (Oγ) is detached from the cation at a distance of
3.0 Å, see Fig. 3A. The second Zn2+ ion (Zn2þ2 ) holds the incom-
ing phosphate group of lipid A and guides it to the phosphate
group attached to Thr285. In the reactant state, lipid A coordi-
nates Zn2þ2 through one oxygen of the phosphate group (the
prospective nucleophile); coordination strengthens in the TS
Table 1 Calculated barrier heights (ΔG‡) and reaction energies (ΔG,
kcal mol−1) for different numbers of Zn2+ ions and different reaction
pathways. SCS-RI-MP2/aug-cc-pVTZ//B3LYP-GD3BJ/B1a





ΔG‡ Not found 12.0
ΔG −10.5
a SCS-RI-MP2 single point calculations on geometries optimised at
DFT level of theory, taking into account the free energy and solvent
corrections from DFT calculations, see Table S4.† B1 = 6-31+G(d,p) for
the P and the O atoms coordinated to Zn, the SDD Stuttgart/Dresden
ECP for Zn, and the 6-31G(d) basis set for all other atoms.
Fig. 3 Second step of the reaction: PEA transfer to the lipid A. Stationary points of the proposed reaction pathway are shown in 3D as sticks (top,
only selected protons shown, transferring proton in white sphere) and in 2D (bottom). (A) Reactant state after substrate 1 departure and lipid A
binding. (B) Transition state, concerted return of proton transferred in the first step and formation/cleavage of P–O bonds. (C) Product state before
substrate departure. Zn-ligand coordination distances indicated in black.
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with addition of a second oxygen and the nucleophilic oxygen
retaining interaction at a distance of 2.1 Å, see Fig. 3B. Both
Zn2+ ions show favourable tetrahedral coordination through all
the stationary points of the reaction. The transition state
involves proton transfer from Glu246 (protonated in the first
step of the reaction) to Thr285 Oγ, concerted with phosphate
release from Thr285 via cleavage of the bond between Oγ and
the P atom (Fig. 3B). This second step is exothermic
(−10.5 kcal mol−1) and faster than the previous step (free
energy reaction barrier of 12.0 kcal mol−1) according to the
SCS-RI-MP2 calculations with solvent and free energy correc-
tions, see Table 1, S3 and S4.† In the product state, the trans-
ferred phosphoryl group is coordinated to both Zn2+ ions via a
single, bridging oxygen atom. Coordination of by Thr285 is
restored, displacing His466, which coordinates the ion at the
reactant and transition states.
Following the transition state, His466 now coordinates
Zn2þ2 , which is probably required to obtain the product
complex, after phosphoryl transfer and restoration of the
Thr285:Zn2þ1 interaction. We speculate that this additional
coordination of Zn2þ2 may facilitate the release of the modified
lipid A (also coordinated to Zn2þ2 ; Fig. 3C). Subsequently, res-
toration of the enzyme to its resting state would involve release
of Zn2þ2 and restoration of Zn
2þ
1 coordination by His466. It
should be noted, however, that the cluster model employed in
this work does not consider the possibility of any residue from
the transmembrane domain (TMD) coordinating Zn2þ2 . As,
based on comparisons with N. meningitidis EptA, the Zn2þ2 site
may lie close to the TMD in the intact, full-length, enzyme, any
involvement of the TMD in coordinating this ion could pre-
clude this proposed motion of His466. However, as at present
crystal structures are only available for the MCR-1 periplasmic
catalytic domain, additional structural work is necessary
before this point can be clarified.
Role of the Zn2+ ions in the rate-deter-
mining step
Comparison of calculated free energy barriers for the two reac-
tion steps (Table 1) indicates that the first of these (PEA trans-
fer to the protein) is likely to be rate-determining. To analyse
the role of the Zn2+ ion(s) in the rate-limiting step, further
single point calculations on the stationary points were per-
formed at the DFT level, see ESI for details.† Here, the Zn2+
ion was replaced by a +2 point charge and the energy recalcu-
lated without any change in the geometry. The energy differ-
ence between the transition and reactant states does not
increase (as would be expected if the Zn2+ orbitals are directly
involved in the chemical reaction), but instead decreases (see
Table S6†). This result suggests that the Zn2+ does not have a
direct involvement in the reaction, but its function is simply to
hold the reactants in place and to provide electrostatic stabilis-
ation to the TS. In this case, the reaction rate would be
expected to be insensitive to the identity of the metal ion
present, i.e., calculations with different metal ions would be
expected to give similar barrier heights. This is the case when
Zn2+ is replaced with Mg2+ and even Na+ (see Table S6†), in
DFT calculations that do not allow for structural changes. If
the geometry is allowed to change, the barrier height is still
very similar for Mg2+ and increases somewhat for Na+ com-
pared to the value obtained without geometry optimization
(Table S6†). Taken together, these calculations point to the
hypothesis that Zn2+ orbitals are not directly involved in the
reaction.34
Conclusions
We identify a complete reaction mechanism for MCR-1 from
QM calculations on active site models. The first step, direct
transfer of PEA from a membrane phospholipid to Thr285,
involves phosphate cleavage concerted with two proton trans-
fers: one from Thr285 to the carboxylate of Glu246 and another
from His395 to the leaving group. This is the rate-limiting step
and can proceed with a single Zn2+ ion. This Zn2+ ion is impor-
tant for structural organisation of the active site with the bound
substrate and presumably for transition state stabilisation, but
the involvement of its orbitals in the chemical reaction is
limited. In contrast to the first step, transfer of PEA to lipid A
cannot proceed without a second Zn2+ metal ion, implying that
this must be recruited either directly to the covalent Thr285-
phospho-intermediate or during lipid A binding. Recruitment
of a second zinc ion (Zn2þ2 ) could occur either directly to the
Zn2 site after PEA addition to Thr285 or involve incoming lipid
A arriving with zinc already attached to the acceptor phosphate
group. In addition, deprotonated His395, generated after the
first step of the reaction, may also contribute to binding, con-
sistent with recent proposals regarding the role of histidine resi-
dues as cation recruiters in phosphate processing enzyme
systems.35 This step is predicted to have a lower barrier and to
be more exothermic than the first step of the reaction mecha-
nism. This proposed “ping-pong” reaction mechanism shares
similarities with those of alkaline phosphatase enzymes,36,37
see ESI† for details, but is distinguished from these by the
ability to transfer PEA from a membrane phospholipid to
Thr285 using a single, rather than two, Zn2+ ion.
By identifying species along the reaction pathway and estab-
lishing the contributions of specific active site residues to the
MCR catalytic mechanism, we here provide detailed mechanis-
tic proposals with implications for future development of
inhibitors for MCR and related enzymes. Co-administration
with inhibitors of resistance represents a validated strategy to
extend the therapeutically useful lifetime of antibiotics.38 In
this instance, our findings suggest that approaches that hinder
metal ion access to a second zinc site represent one possible
route to MCR inhibition.39
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